UK regulator calls for new rules to keep AI in healthcare safe and trusted
BBC - 10-Sep-2026AI in healthcare needs lifelong monitoring and patient rights, says UK report
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator of medicines and medical devices
Lawrence Tallon became chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA) on 1 April 2025, succeeding Dame June Raine. The MHRA regulates medicines, medical devices and blood components for transfusion in the UK.
Before joining the MHRA he was deputy chief executive of Guy's and St Thomas' NHS Foundation Trust from 2020, where he led strategy, technology, innovation and improvement, and was managing director of the Shelford Group of leading NHS teaching hospitals. He holds a master's degree in health policy from Imperial College London. He has spoken about the need to update UK rules so that AI tools used in healthcare can be monitored throughout their use.
Visit website: https://www.gov.uk/government/people/lawrence-tallon
See also
Regulates medicines, medical devices and blood components for transfusion in the UK
Details last updated 05-Nov-2026
AI in healthcare needs lifelong monitoring and patient rights, says UK report